Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer

Conditions:   Breast Cancer;   Triple Negative Breast Cancer;   HER2-positive Breast Cancer Interventions:   Drug: Nab-paclitaxel;   Drug: Carboplatin;   Drug: Herceptin Sponsor:   Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials